FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing N-((hydroxyamino)-oxoalkyl)-2-(quinazolin-4-ylamino)-benzamide derivatives of general formula given below. In general formula R1 and R2 independently of each other are H, Cl, Br, OMe.
EFFECT: invention can be used in treating malignant growths.
3 cl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING HYDROXAMIC ACIDS, DERIVATIVES OF 2-ARYL-2.3-DIHYDROQUINAZOLIN-4(1H)-ONES | 2020 |
|
RU2744750C1 |
| HYDROXAMIC ACIDS, DERIVATIVES OF 4-AMINOQUINAZOLINE-7-CARBOXYLIC ACID AS INHIBITORS OF HISTONE DEACETYLASE, AND METHOD FOR SYNTHESIS THEREOF | 2021 |
|
RU2779981C1 |
| 3-HYDROXYQUINAZOLINE-4(3H)-ONE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS AND A METHOD FOR PRODUCTION THEREOF | 2020 |
|
RU2740503C1 |
| HYDROXAMIC ACIDS, 4-AMINOQUINAZOLINE DERIVATIVES WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2802463C1 |
| METHODS FOR PREPARING 2-(7-CHLORO-1,8-NAPHTHYRIDINE-2-YL)-3-(5-METHYL-2-OXOHEXYL)-1-ISOINDOLINONE | 2003 |
|
RU2318823C2 |
| HETEROCYCLIC ALKYL DERIVATIVE COMPOUNDS AS THE HISTONE DEACETYLASE SELECTIVE INHIBITORS AND CONTAINING THEM PHARMACEUTICAL COMPOSITIONS | 2016 |
|
RU2683022C1 |
| NOVEL 4-AMINO-N-HYDROXYBENZAMIDES AS HDAC INHIBITORS FOR TREATING CANCER | 2012 |
|
RU2591190C2 |
| JAK KINASE-MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2529019C2 |
| 2,3,5-TRISUBSTITUTED PYRROLS, BASED PHARMACEUTICAL COMPOSITION AND DRUG, METHOD FOR PREPARING COMPOUNDS (VERSIONS) | 2010 |
|
RU2549885C2 |
| AZAINDAZOLE OR DIAZAINDAZOLE DERIVATIVES AS MEDICINE | 2012 |
|
RU2600976C2 |
